Liquid Handling Systems Market Analysis

Liquid Handling System Market Analysis

To get key market trends

  Download Free Sample

Manual liquid handling system market size is anticipated to expand at 5.3% CAGR from 2023-2032. The growth is attributed to the low cost and reduction in sample processing times offered by manual liquid handling systems in diagnostic facilities, biotechnology firms, and research institutions. The growing R&D investments has pushed numerous pharmaceutical companies to emphasize more on drug development. For instance, ClinicalTrials.gov reported 452,604 clinical studies, as of May 2023. Furthermore, the ongoing research investigations will drive the adoption of manual liquid handling systems, fueling the segment expansion.
 

Liquid handling system market size from the automated workstation segment is anticipated to record 6.7% CAGR from 2023-2032. This is driven by widespread product usage by increasing number of biotech and research firms due to the scarcity of skilled laboratory experts. For example, in 2021, around 6,600 biotech businesses in the U.S. employed therapeutics as the most prevalent field in the biotech landscape. Furthermore, the rising necessity for continuous quality library prep and better throughput has prompted industry participants to address these requirements, in turn, adding to the market growth. For instance, in July 2023, Revvity introduced FontusTM Automated Liquid Handling Workstation, a next-generation liquid handler designed to deliver easier and faster workflows for improved outcomes in diagnostic studies.
 

Liquid handling system market size from the drug discovery segment is expected to generate more than USD 2.2 billion by the end of 2032 owing to the rising burden of broad range of diseases and the increasing usage of high throughput screening for better drug candidate identification. The COVID-19 pandemic also spurred the number of research activities for drug discovery for the treatment of infectious diseases. The rising advancements in lab automation, integration with data analytics, and miniaturization of assays coupled with the increasing focus on personalized medicine and novel therapies will add to the segment expansion.
 

North America liquid handling systems market size is anticipated to reach over USD 2 billion by 2032. The rising burden of diseases and the higher R&D expenditures are major factors driving the market expansion. According to the American Cancer Society, 1.9 million new cancer cases were reported in the U.S. in 2022. The strong presence of well-known companies, such as Agilent Technologies, Inc. along with the thriving clinical trials for the treatment of cancer will support the regional industry growth.